GlaxoSmithKline Pakistan Limited (PSX:GLAXO)

GlaxoSmithKline Pakistan Balance Sheet

Financials in millions PKR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8,145	8,592	6,513	3,611	4,755	7,085
Short-Term Investments	-	-	-	-	-	1,633
Cash & Short-Term Investments	8,145	8,592	6,513	3,611	4,755	8,719
Cash Growth	16.24%	31.91%	80.39%	-24.06%	-45.47%	43.98%
Accounts Receivable	5,211	2,813	555.14	1,028	1,585	1,316
Other Receivables	6,258	8,991	10,337	7,506	5,582	1,669
Receivables	13,349	11,858	10,947	8,587	7,217	3,043
Inventory	16,538	13,068	11,447	11,794	9,726	6,696
Prepaid Expenses	-	185.98	181.1	190.75	123	7.21
Other Current Assets	170.42	1,452	1,610	1,158	1,682	503.93
Total Current Assets	38,202	35,156	30,698	25,341	23,503	18,969
Property, Plant & Equipment	14,447	14,433	13,262	11,701	10,997	10,408
Goodwill	955.74	955.74	955.74	955.74	955.74	955.74
Other Intangible Assets	-	-	-	-	-	36
Other Long-Term Assets	50.76	50.15	50.15	50.15	27.52	22.01
Total Assets	53,763	50,684	45,055	38,131	35,542	30,455

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	16,917	1,308	1,089	1,616	560.52	652.17
Accrued Expenses	-	8,237	7,147	5,404	4,098	3,776
Short-Term Debt	-	246.51	198.63	572.93	284.14	235.75
Current Portion of Leases	30.87	32.97	27.89	35.94	16.5	20.89
Current Income Taxes Payable	-	989.29	1,443	68.69	936.81	1,116
Current Unearned Revenue	-	1,833	1,971	2,432	2,368	1,051
Other Current Liabilities	438.69	2,487	3,057	4,436	4,645	1,479
Total Current Liabilities	17,387	15,134	14,933	14,565	12,909	8,330
Long-Term Leases	307.11	335.14	145.76	116.04	45.42	32.71
Pension & Post-Retirement Benefits	329.76	612.44	636.36	593.71	577.8	298.89
Long-Term Deferred Tax Liabilities	924.04	927.43	1,064	1,181	957	806.63
Total Liabilities	18,948	17,009	16,779	16,455	14,489	9,469

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	3,185	3,185	3,185	3,185	3,185	3,185
Retained Earnings	30,503	29,363	23,965	17,364	16,742	16,675
Comprehensive Income & Other	1,127	1,127	1,127	1,127	1,127	1,127
Shareholders' Equity	34,815	33,675	28,277	21,676	21,053	20,987
Total Liabilities & Equity	53,763	50,684	45,055	38,131	35,542	30,455

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	337.98	614.63	372.28	724.9	346.07	289.36
Net Cash (Debt)	7,807	7,978	6,141	2,886	4,408	8,429
Net Cash Growth	17.58%	29.90%	112.80%	-34.54%	-47.70%	48.37%
Net Cash Per Share	24.52	25.05	19.28	9.06	13.84	26.47
Filing Date Shares Outstanding	318.35	318.47	318.47	318.47	318.47	318.47
Total Common Shares Outstanding	318.35	318.47	318.47	318.47	318.47	318.47
Working Capital	20,815	20,022	15,766	10,776	10,595	10,639
Book Value Per Share	109.36	105.74	88.79	68.06	66.11	65.90
Tangible Book Value	33,859	32,719	27,321	20,720	20,097	19,995
Tangible Book Value Per Share	106.36	102.74	85.79	65.06	63.11	62.78
Land	-	316.41	316.41	316.41	316.41	316.41
Buildings	-	3,404	3,102	3,080	3,001	2,928
Machinery	-	15,839	14,393	13,856	12,773	12,119
Construction In Progress	-	3,333	3,087	1,295	1,236	1,178

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error